This study provides the most comprehensive dynamic survival assessment of PUTL to date. CS analysis revealed a favorable shift in prognosis over time, particularly for patients who survived the high-risk early phase. The CS-nomogram enables personalized, time-updated prognostic estimates, supporting more accurate counseling, follow-up planning, and resource optimization in this rare disease.
Ke et al. (Sat,) studied this question.